Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (455)

« Back to Publications

A changing HIV treatment landscape: what does lenacapavir mean for people living with HBV?

Matthews PC. et al, (2026), Lancet Gastroenterology and Hepatology, 11, 542 - 543

Emergency Department Opt-Out Testing for Hepatitis B: A Two-Year UK Multicentre Evaluation of Outcomes Across Seven Sites.

Plunkett JJ. et al, (2026), Liver Int, 46

From targets to real world impact: a review of models of care for chronic HBV and HCV in Europe

Picchio CA. et al, (2026), Lancet Regional Health Europe, 65

Global inequities in hepatitis B and C genomic surveillance revealed through an interactive data integration dashboard.

Tshiabuila D. et al, (2026), Public Health, 257

What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol

Martyn E. et al, (2026), Wellcome Open Research, 11, 285 - 285

Diagnosing and defining MASLD in people living with chronic hepatitis B.

Martyn E. et al, (2026), Commun Med (Lond), 6

Voices from the frontline: how global funding cuts are reshaping the viral hepatitis response.

Delphin M. et al, (2026), Lancet Gastroenterol Hepatol, 11, 269 - 271

Towards the endgame: achieving elimination of viral hepatitis in England.

Mandal S. et al, (2026), Lancet Microbe, 7

‘EVOLVE-HBV’: A retrospective cross-sectional study to quantify and characterise HBV infection, exposure, immunity and susceptibility in a rural population in KwaZulu-Natal, South Africa

Anderson M. et al, (2026)

Research without borders: advancing equitable global partnerships to accelerate HBV elimination efforts.

Batbold E. et al, (2026), Nat Rev Gastroenterol Hepatol

HepB-boost: Implementation of free-of-charge health care worker hepatitis B testing and vaccination at Kilifi County Referral Hospital, Kenya.

Downs LO. et al, (2026), Int J Infect Dis, 164

Evidence for a relationship between concentrations of nucleos/tide analogue agents and treatment outcome in chronic hepatitis B infection: A systematic review

Sukali G. et al, (2026)

Response to Comments on 'Hepatitis B Virus (HBV) Treatment Eligibility in the UK: Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines'.

Campbell C. et al, (2026), J Viral Hepat, 33

Eligibility for hepatitis B virus (HBV) treatment and prevalence of drug resistance in a Ugandan population cohort.

Lumley SF. et al, (2026), J Infect, 92

Micro-elimination of Hepatitis C virus (HCV) infection in the General Population Cohort in rural Uganda: Long-term follow-up to assess feasibility and outcomes of a screening and treatment intervention.

Mugisha J. et al, (2026), J Clin Virol, 182

Load More

1
2
3
4
5
6
7
...
»